These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. 99mTc(CO)3-nitrilotriacetic acid: a new renal radiopharmaceutical showing pharmacokinetic properties in rats comparable to those of 131I-OIH. Lipowska M, Marzilli LG, Taylor AT. J Nucl Med; 2009 Mar; 50(3):454-60. PubMed ID: 19223406 [Abstract] [Full Text] [Related]
4. (99m)Tc(CO)3(NTA): a (99m)Tc renal tracer with pharmacokinetic properties comparable to those of (131)I-OIH in healthy volunteers. Taylor AT, Lipowska M, Marzilli LG. J Nucl Med; 2010 Mar; 51(3):391-6. PubMed ID: 20150248 [Abstract] [Full Text] [Related]
5. Preclinical evaluation of 99mTc(CO)3-aspartic-N-monoacetic acid, a renal radiotracer with pharmacokinetic properties comparable to 131I-o-iodohippurate. Lipowska M, Klenc J, Marzilli LG, Taylor AT. J Nucl Med; 2012 Aug; 53(8):1277-83. PubMed ID: 22717977 [Abstract] [Full Text] [Related]
6. 99mTc(CO)3(NTA) and 131I-OIH: comparable plasma clearances in patients with chronic kidney disease. Taylor AT, Lipowska M, Cai H. J Nucl Med; 2013 Apr; 54(4):578-84. PubMed ID: 23424193 [Abstract] [Full Text] [Related]
9. First evaluation of a 99mTc-tricarbonyl complex, 99mTc(CO)3(LAN), as a new renal radiopharmaceutical in humans. Lipowska M, He H, Malveaux E, Xu X, Marzilli LG, Taylor A. J Nucl Med; 2006 Jun; 47(6):1032-40. PubMed ID: 16741314 [Abstract] [Full Text] [Related]
11. 99mTc-MAEC complexes: new renal radiopharmaceuticals combining characteristics of (99m)Tc-MAG3 and (99m)Tc-EC. Taylor AT, Lipowska M, Hansen L, Malveaux E, Marzilli LG. J Nucl Med; 2004 May; 45(5):885-91. PubMed ID: 15136640 [Abstract] [Full Text] [Related]
12. Initial Evaluation of (99m)Tc(CO)3(ASMA) as a Renal Tracer in Healthy Human Volunteers. Lipowska M, Klenc J, Folks RD, Taylor AT. Nucl Med Mol Imaging; 2014 Sep; 48(3):216-24. PubMed ID: 25177379 [Abstract] [Full Text] [Related]
13. Necrosis avidity of (99m)Tc(CO)3-labeled pamoic acid derivatives: synthesis and preliminary biological evaluation in animal models of necrosis. Fonge H, Chitneni SK, Lixin J, Vunckx K, Prinsen K, Nuyts J, Mortelmans L, Bormans G, Ni Y, Verbruggen A. Bioconjug Chem; 2007 Sep; 18(6):1924-34. PubMed ID: 17929883 [Abstract] [Full Text] [Related]
15. Somatostatin receptor targeting with hydrophilic [99mTc/186Re]Tc/Re-tricarbonyl NODAGA and NOTA complexes. Makris G, Kuchuk M, Gallazzi F, Jurisson SS, Smith CJ, Hennkens HM. Nucl Med Biol; 2019 Apr; 71():39-46. PubMed ID: 31129499 [Abstract] [Full Text] [Related]
16. Novel Approach for 99mTc-Labeling of Red Blood Cells: Evaluation of 99mTc-4SAboroxime as a Blood Pool Imaging Agent. Liu M, Zhao ZQ, Fang W, Liu S. Bioconjug Chem; 2017 Dec 20; 28(12):2998-3006. PubMed ID: 29148726 [Abstract] [Full Text] [Related]
17. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging. Ortiz-Arzate Z, Santos-Cuevas CL, Ocampo-García BE, Ferro-Flores G, García-Becerra R, Estrada G, Gómez-Argumosa E, Izquierdo-Sánchez V. Nucl Med Commun; 2014 Apr 20; 35(4):423-32. PubMed ID: 24335877 [Abstract] [Full Text] [Related]